Standardized Reporting of Myocardial Perfusion SPECT Imaging
Journal Title: Nuclear Medicine Seminars - Year 2020, Vol 6, Issue 2
Abstract
Myocardial perfusion single photon emission computerized tomography (MPS) report is the final product of a series of complex procedures, starting with patient preparation and ending with interpretation of the process. The report should summarize the patient’s identity, the purpose(s) of the test, all the procedures, drugs and radiopharmaceuticals performed, and the characteristics of the practicing physician and clinic as much as clearly possible. The aim of this guide is to assist nuclear physicians in MPS studies, especially during the reporting phase.The recommendations in this guide were prepared by “Turkey Society of Nuclear Medicine Cardiology Task Group”, to ensure the standardization of our MPS reporting in our country, considering the developments and contribution of the structured reporting into the clinical practice in the light of international studies and current guidelines.
Authors and Affiliations
Fevziye Canbaz Tosun, Hakan Demir, Cengiz Taşçı, Elif Özdemir, Semra Özdemir, Feyza Şen, Gülay Durmuş Altun
Differentiated Thyroid Carcinoma in Pediatric Age Group/Differences in Diagnosis, Therapy and Follow-up
Differentiated thyroid cancer in childhood is rare. Although its clinical course is quite aggressive with higher rates of lymph node and pulmonary metastases as compared to adults, the final outcome tends to be favorable...
New Radionuclides in Pain Palliation
Skeletal system is the most common metastasis site in patients with advanced cancer. Pain is an important health problem in patients with bone metastasis. Bone seeking radionuclides to treat bone pain due to bone metasta...
Nuclear Medicine in Urinary Tract İnfection
Urinary tract infections (UTIs) are frequent in pediatric population and have various clinical presentations. Definitive diagnosis is made by urinalysis and quantitative urine culture, and antibiotic treatment is usually...
Essentials of Thyroid Hormone Treatment in Differentiated Thyroid Cancer
Levothyroxine is used for both hormone replacement and suppression of thyroid stimulating hormone (TSH) secretion from pituitary gland at supraphysiological doses in differentiated thyroid cancer (DTC). The impact of TSH...
Practical Guidance on Peptide Receptor Radionuclide Therapy
Peptide receptor radionuclide therapy (PRRT) have been successfully used for the past 20 years to target metastatic or inoperable neuroendocrine tumors expressing the somatostatin receptors. Both prospective and retrospe...